6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
11m ago	FatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m ago	Angle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
38m ago	Century Complete Announces New Homes Coming Soon to Fleming Island, FL
38m ago	Sprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
39m ago	Tambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

About

Kala Pharmaceuticals Inc (NASDAQ:KALA) — investor relations, events, news, and company updates on 6ix.

Latest News

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live

Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate

Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate

Financials

Revenue

$0

Market Cap

$155.11 M

EPS

-5.64

Community Chat

Ask AI